Leef Brands Swings to $281,941 Q3 Profit as Gross Margin Jumps to 41%
LEEEF sits 47% above its 52-week low of $0.105 on light trading volume (0.2× avg).
Summary
Leef Brands reported Q3 2026 net income of $281,941 versus a $3,803,812 loss a year ago, driven largely by a $2,066,285 non-cash derivative gain, while nine-month gross margin expanded to 41% and cash rose to $5,895,529. The going-concern warning and a $22,823,077 uncertain tax liability remain.
Key Events · Earnings and Guidance · LEEEF
-
Q3 Swings to $281,941 Profit
Net income of $281,941 versus a $3,803,812 net loss in Q3 2025, a $4,085,753 favorable swing driven mainly by a $2,066,285 non-cash gain on derivative remeasurement.
-
Gross Margin Expands to 41%
Nine-month gross profit rose to $10,116,946 (41% of $24,724,340 revenue) from $6,695,587 (25% of $26,469,224), as Salisbury Canyon Ranch biomass displaced third-party inputs; revenue still fell 6.6% on California wholesale pricing pressure.
-
Cash Doubles, Working Capital Turns Positive
Cash reached $5,895,529 from $2,190,722 at December 31, 2025, and working capital moved to a $10,790,336 surplus after roughly $14.2 million of equity raised through July 2026.
-
Going Concern and Tax Exposure Persist
The filing repeats substantial doubt about ability to continue as a going concern and carries a $22,823,077 uncertain tax position liability, up from $15,219,548, plus a $10,058,171 derivative liability.
Analysis · LEEEF · Life Sciences
The headline $281,941 Q3 2026 net profit, versus a $3,803,812 loss a year earlier, is mostly accounting: a $2,066,285 non-cash gain on derivative remeasurement, not operations. The real operational story is margin. Nine-month gross profit rose to $10,116,946 (41% of revenue) from $6,695,587 (25%) as Salisbury Canyon Ranch biomass replaced third-party inputs, even though revenue fell 6.6% to $24,724,340 on California wholesale price pressure. Cash more than doubled to $5,895,529 and working capital turned to a $10,790,336 surplus after roughly $14.2 million of equity raised through July 2026. Against that, the filing still carries an explicit going-concern warning, a $22,823,077 uncertain tax position, and a $10,058,171 derivative liability tied to warrants and preferred conversion features. There is also 33,644,053 Series A-2 preferred shares convertible at US$0.25 with a down-round ratchet that can dilute common holders if shares are issued below that price.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LEEEF was trading at $0.15 on OTC in the Life Sciences sector, with a market capitalization of approximately $46.9M. The 52-week trading range was $0.10 to $0.24. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.